CRC
GNMK

Curi RMB Capital’s GenMark Diagnostics, Inc GNMK Stock Holding History

Curi RMB Capital’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-82,589
Closed -$795K – 976
2017
Q3 		$795K Sell
82,589
-217,904
-73% -$2.26M 0.02% 458
2017
Q2 		$3.56M Sell
300,493
-501,372
-63% -$6.41M 0.1% 278
2017
Q1 		$10.3M Hold
801,865
– – 0.43% 77
2016
Q4 		$9.81M Hold
801,865
– – 0.53% 67
2016
Q3 		$9.46M Sell
801,865
-358,565
-31% -$3.46M 0.51% 61
2016
Q2 		$10.1M Hold
1,160,430
– – 0.53% 55
2016
Q1 		$6.12M Hold
1,160,430
– – 0.4% 79
2015
Q4 		$9.01M Buy
1,160,430
+82,303
+8% +$632K 0.42% 61
2015
Q3 		$8.48M Buy
1,078,127
+7,787
+0.7% +$72K 0.56% 55
2015
Q2 		$9.7M Buy
1,070,340
+9,955
+0.9% +$100K 0.63% 48
2015
Q1 		$13.8M Buy
1,060,385
+8,452
+0.8% +$111K 0.83% 35
2014
Q4 		$14.3M Buy
1,051,933
+19,563
+2% +$219K 0.87% 31
2014
Q3 		$9.26M Buy
1,032,370
+1
+0% +$11 0.57% 49
2014
Q2 		$14M Buy
1,032,369
+42,798
+4% +$447K 0.88% 29
2014
Q1 		$9.84M Buy
989,571
+35,011
+4% +$435K 0.68% 48
2013
Q4 		$12.7M Sell
954,560
-43,116
-4% -$524K 0.88% 38
2013
Q3 		$12.1M Buy
997,676
+58,411
+6% +$626K 0.87% 36
2013
Q2 		$9.72M Buy
+939,265
New +$13M 0.74% 48

Other funds holding GNMK

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Curi RMB Capital's GNMK Position: Q4 2017 in Review

Curi RMB Capital sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2017, closing a stake of 82,589 shares — an estimated $795K sold.

Curi RMB Capital first reported a position in GNMK in Q2 2013 and held it in 18 quarters. The position peaked at $14.3M in Q4 2014. 99 funds tracked by Wall St. Rank hold GNMK as of Q4 2017.

  • Curi RMB Capital reported no remaining GenMark Diagnostics, Inc position as of Q4 2017 after selling out during the quarter.
  • Curi RMB Capital sold 82,589 GenMark Diagnostics, Inc shares in Q4 2017, an estimated $795K.
  • Curi RMB Capital first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 18 quarters.
  • Curi RMB Capital's GenMark Diagnostics, Inc position peaked at $14.3M in Q4 2014.
  • 99 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2017.

Based on Curi RMB Capital's 13F filing for Q4 2017, filed 14 Feb 2018.